Please use this identifier to cite or link to this item:
|Title:||Understanding alternative splicing of Cav 1.2 calcium channels for a new approach towards individualized medicine|
|Citation:||Liao, P., Soong, T.W. (2010-05). Understanding alternative splicing of Cav 1.2 calcium channels for a new approach towards individualized medicine. Journal of Biomedical Research 24 (3) : 181-186. ScholarBank@NUS Repository. https://doi.org/10.1016/S1674-8301(10)60027-9|
|Abstract:||Calcium channel blockers (CCBs) are widely used to treat cardiovascular diseases such as hypertension, angina pectoris, hypertrophic cardiomyopathy, and supraventricular tachycardia. CCBs selectively inhibit the inward flow of calcium ions through voltage-gated calcium channels, particularly Cav 1.2, that are expressed in the cardiovascular system. Changes to the molecular structure of Cav 1.2 channels could affect sensitivity of the channels to blockade by CCBs. Recently, extensive alternative splicing was found in Cav 1.2 channels that generated wide phenotypic variations. Cardiac and smooth muscles express slightly different, but functionally important Cav 1.2 splice variants. Alternative splicing could also modulate the gating properties of the channels and giving rise to different responses to inhibition by CCBs. Importantly, alternative splicing of Cav 1.2 channels may play an important role to influence the outcome of many cardiovascular disorders. Therefore, the understanding of how alternative splicing impacts Cav 1.2 channels pharmacology in various diseases and different organs may provide the possibility for individualized therapy with minimal side effects. © 2010 The Editorial Board of Journal of Biomedical Research.|
|Source Title:||Journal of Biomedical Research|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Sep 13, 2018
WEB OF SCIENCETM
checked on Sep 4, 2018
checked on Jun 14, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.